The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...

Medtronic plc MDT recently received the FDA’s approval for the Percept RC Deep Brain Stimulation (“DBS”) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept ...

ABBOTT PARK, Ill., Sept. 4, 2024 /PRNewswire/ -- Abbott announced today it has initiated a pivotal clinical trial, called the TRANSCEND study, to evaluate the use of the company's deep brain ...

(RTTNews) - Abbott (ABT) announced the FDA has granted Breakthrough Device Designation to investigate the use of its deep brain stimulation system in treatment-resistant depression. Abbott's DBS ...

European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease For 30 years, people with Parkinson's disease ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

Abbott Laboratories received U.S. FDA clearance for its Liberta RC deep brain stimulation (DBS) system for use in movement disorders, less than two weeks after the agency gave its nod to Medtronic’s ...